SCHEMBL14033481

SCHEMBL14033481

O=S(O)c1sccc1-c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.37
CASP3 P42574 1/20 0.37
AURKA O14965 1/20 0.37
TPX2 Q9ULW0 1/20 0.37
MAPK8 P45983 1/20 0.36
KIF11 P52732 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SCN5A Q14524 2/20 0.35
SCN1A P35498 1/20 0.35
KCNH2 Q12809 1/20 0.35
SCN9A Q15858 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN8A Q9UQD0 1/20 0.35
SCN10A Q9Y5Y9 1/20 0.35
ERCC5 P28715 1/20 0.35
FEN1 P39748 1/20 0.35
NOTUM Q6P988 1/20 0.35
AKR1C2 P52895 1/20 0.35
AKR1C1 Q04828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5123239 0.99 CASP3 (0.36) EPHX2CASP3AURKATPX2MAPK8
SCHEMBL5123243 0.84 CASP3 (0.36) EPHX2CASP3AURKATPX2MAPK8
SCHEMBL5052822 0.73 CASP3 (0.41) CASP3KIF11NPC1RAB9ASCN5A
SCHEMBL14605699 0.73 KIF11 (0.41) EPHX2CASP3AURKATPX2MAPK8
SCHEMBL5055342 0.71 KIF11 (0.42) EPHX2CASP3AURKATPX2MAPK8
SCHEMBL10344487 0.70 EPHX2 (0.48) EPHX2AURKATPX2KIF11NPC1
SCHEMBL5051722 0.70 POLQ (0.38) AURKATPX2KIF11SCN5ASCN1A
SCHEMBL5134293 0.70 KIF11 (0.45) EPHX2CASP3AURKATPX2MAPK8
SCHEMBL1584405 0.69 EPHX2 (0.47) EPHX2AURKATPX2KIF11NPC1
SCHEMBL5134292 0.67 KIF11 (0.45) MAPK8KIF11SCN9AERCC5FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249137-A1 PPAR active compounds PLEXXIKON INC 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249137-A1 PPAR active compounds PPARG, PPARA, PPARD EPHX2 3169/4885CASP3 1482/4885AURKA 4674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.